Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms

Future Medicinal Chemistry
Nicolas DelattinKarin Thevissen

Abstract

Invasive fungal infections are associated with very high mortality rates ranging from 20-90% for opportunistic fungal pathogens such as Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. Fungal resistance to antimycotic treatment can be genotypic (due to resistant strains) as well as phenotypic (due to more resistant fungal lifestyles, such as biofilms). With regard to the latter, biofilms are considered to be critical in the development of invasive fungal infections. However, there are only very few antimycotics, such as miconazole (azoles), echinocandins and liposomal formulations of amphotericin B (polyenes), which are also effective against fungal biofilms. Interestingly, these antimycotics all induce reactive oxygen species (ROS) in fungal (biofilm) cells. This review provides an overview of the different classes of antimycotics and novel antifungal compounds that induce ROS in fungal planktonic and biofilm cells. Moreover, different strategies to further enhance the antibiofilm activity of such ROS-inducing antimycotics will be discussed.

References

Feb 1, 1990·Antimicrobial Agents and Chemotherapy·J BrajtburgG Medoff
Jan 1, 1988·Current Topics in Medical Mycology·Y Yoshida
Jul 1, 1986·The Journal of Infectious Diseases·M L Sokol-AndersonG Medoff
Feb 1, 1996·Antimicrobial Agents and Chemotherapy·N H Georgopapadakou, T J Walsh
Jan 12, 2001·Journal of Chemotherapy·V Fanos, L Cataldi
Nov 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·E J HelmerhorstF G Oppenheim
Jan 22, 2002·The Journal of Antimicrobial Chemotherapy·David Ellis
May 23, 2002·Antimicrobial Agents and Chemotherapy·Antonella LupettiPeter H Nibbering
Sep 18, 2002·Antimicrobial Agents and Chemotherapy·Daisuke KobayashiNaoki Watanabe
Dec 17, 2002·Molecular and Cellular Biology·Jijun ChengXiang S Ye
Jul 29, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Luis Ostrosky-ZeichnerStuart H Cohen
Oct 11, 2003·Lancet·David W Denning
Nov 19, 2003·Proceedings of the National Academy of Sciences of the United States of America·Andrew J PhillipsMark Ramsdale
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·David WunderMira Edgerton
Apr 16, 2004·Clinical Microbiology Reviews·Erna M Kojic, Rabih O Darouiche
Apr 28, 2004·The Biochemical Journal·Enno C I VeermanArie V Nieuw Amerongen
Aug 4, 2004·The Journal of Cell Biology·Robert Wysocki, Stephen J Kron
Mar 2, 2005·International Journal of Antimicrobial Agents·M Carmen RubioAntonio Rezusta
Feb 24, 2006·Antimicrobial Agents and Chemotherapy·Luis R Martinez, Arturo Casadevall
Aug 23, 2006·Antimicrobial Agents and Chemotherapy·Michael D LaFleurKim Lewis
Oct 18, 2006·FEMS Yeast Research·Gordon RamageJosé Luis López-Ribot
Jun 8, 2007·The Journal of Biological Chemistry·Karin ThevissenIsabelle E J A François
Sep 7, 2007·Cell·Michael A KohanskiJames J Collins
Sep 29, 2007·Journal of Medicinal Chemistry·Bin YaoHui Tang
Oct 17, 2007·Antimicrobial Agents and Chemotherapy·Aspasia KatragkouEmmanuel Roilides
Jan 4, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Zeina A Kanafani, John R Perfect
Feb 13, 2008·Antimicrobial Agents and Chemotherapy·Gerhard BlumCornelia Lass-Flörl
Jun 6, 2008·Bioorganic & Medicinal Chemistry Letters·Karin ThevissenIsabelle E J A François
Jul 16, 2008·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Chih-Cheng LaiPo-Ren Hsueh
Jul 16, 2008·Journal of Biomolecular Screening·Damian J Krysan, Louis Didone
Jul 26, 2008·Proteomics·C Jayampath SeneviratneLakshman P Samaranayake
Aug 20, 2008·Antimicrobial Agents and Chemotherapy·María T AndrésJosé F Fierro
Sep 30, 2008·The Journal of Antimicrobial Chemotherapy·Eilidh MowatGordon Ramage
Oct 24, 2008·International Journal of Antimicrobial Agents·Pranab K MukherjeeMahmoud A Ghannoum
Dec 20, 2008·International Journal of Antimicrobial Agents·MaoMao AnYuanYing Jiang
May 5, 2009·Microbes and Infection·Fahmi HasanBettina C Fries

❮ Previous
Next ❯

Citations

Aug 6, 2014·Intensive Care Medicine·Danièle MaubonMuriel Cornet
Jun 14, 2015·Expert Review of Anti-infective Therapy·Kaat De CremerKatrijn De Brucker
Jun 7, 2014·Cellular Microbiology·Deborah Hogan, Robert T Wheeler
Sep 22, 2015·Frontiers in Molecular Biosciences·Ana M Carmona-RibeiroIseli L Nantes
Sep 27, 2015·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Mariana Andrea PeraltaMaría Gabriela Paraje
Sep 10, 2015·Der Anaesthesist·C ArensC Lichtenstern
Jul 15, 2015·Microbial Pathogenesis·TianMing WangChangZhong Wang
May 6, 2015·International Journal of Antimicrobial Agents·ZeBin LiaoYingYing Cao
Nov 5, 2014·Antimicrobial Agents and Chemotherapy·Kaat De CremerKarin Thevissen
Oct 22, 2016·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Juliana MarioniMaría Gabriela Paraje
Aug 6, 2016·Mechanisms of Ageing and Development·Sara VerbandtKarin Thevissen
Nov 5, 2016·International Journal of Antimicrobial Agents·Taissa VilaSonia Rozental
Nov 14, 2016·Bioorganic & Medicinal Chemistry Letters·Daniela De VitaLuigi Scipione
Oct 8, 2014·The Journal of Antimicrobial Chemotherapy·Aspasia KatragkouThomas J Walsh
Apr 4, 2018·Antimicrobial Agents and Chemotherapy·Virginia BassoMichael E Selsted
Mar 31, 2018·The Pediatric Infectious Disease Journal·Ingmar FortmannUNKNOWN German Neonatal Network
Nov 15, 2019·Clinical Microbiology Reviews·Jean-Paul Latgé, Georgios Chamilos
Jun 2, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Longfei YangTonghui Ma
Dec 24, 2019·Frontiers in Cellular and Infection Microbiology·Junya de Lacorte SingulaniMaria José Soares Mendes Giannini
Jun 13, 2020·Antibiotics·Somanon BhattacharyaBettina C Fries
Nov 7, 2019·Oxidative Medicine and Cellular Longevity·Cristian Cezar LoginŞoimiţa Suciu
Nov 14, 2017·Oxidative Medicine and Cellular Longevity·Kim VriensKarin Thevissen
Jun 2, 2017·Frontiers in Microbiology·Tao WangXiaoli Shang
Aug 31, 2019·International Journal of Molecular Sciences·Pramod ShahChien-Sheng Chen
May 23, 2020·Advanced Science·Samuel CheesemanAaron Elbourne
Jun 14, 2019·Zeitschrift Für Naturforschung. C, a Journal of Biosciences·Vanya MantarevaIvan Angelov
Sep 15, 2020·Journal of Oral Microbiology·Laís Salomão AriasGordon Ramage
Oct 22, 2020·Scientific Reports·Makoto SumiyoshiHiroshi Mukae

❮ Previous
Next ❯

Methods Mentioned

BETA
chemical treatment

Related Concepts

Related Feeds

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Enfermedades infecciosas y microbiología clínica
Carlos LumbrerasJosé María Aguado
Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology
H Yamaguchi
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
M RuhnkeG Kofla
Fungal Genetics and Biology : FG & B
Joachim Morschhäuser
© 2021 Meta ULC. All rights reserved